| HAL |
Report |
C&P Revenue (Q2 2026) |
IN-LINE |
pred ~$3,175M vs cons $3,162M |
MEDIUM |
| HAL |
Report |
Adj. EPS Diluted (Q2 2026) |
BEAT |
pred ~$0.55 vs cons $0.541 |
MEDIUM |
| HAL |
Report |
D&E Revenue (Q2 2026) |
IN-LINE |
pred ~$2,360M vs cons $2,352M |
MEDIUM |
| HAL |
Guide |
C&P Revenue (Q3 2026) |
BETTER |
guide ~$3,302M midpoint vs cons $3,223M |
MEDIUM |
| HAL |
Guide |
D&E Revenue (Q3 2026) |
BETTER |
guide ~$2,431M midpoint vs cons $2,377M |
MEDIUM |
| HAL |
Guide |
Middle East recovery tone (Q3/H2 2026) |
BETTER |
Constructive — offshore restart tracking, H2 ramp intact |
MEDIUM |
| HAL |
Guide |
FY 2026 EBITDA frame |
UNCHANGED |
Reaffirm H2 > H1; ~$4.1B in range vs cons $4,118M |
HIGH |
| HAL |
Return |
Day-1 residual (stock − beta × S&P 500) |
+5.0% |
— |
MEDIUM |
| HAL |
Return |
5-day cumulative residual |
+10.0% (FOLLOW-THROUGH) |
FOLLOW-THROUGH — estimate revisions follow implied out-period math; Q3 and FY estimates move up as Street models better-than-consensus guide |
MEDIUM |